HF
UBX

HRT Financial’s Unity Biotechnology UBX Stock Holding History

HRT Financial’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,641
Closed -$13K – 3705
2025
Q2 		$13K Buy
+34,641
New +$29.7K ﹤0.01% 2437
2021
Q4 		– Sell
-4,944
Closed -$148K – 4100
2021
Q3 		$148K Sell
4,944
-5,018
-50% -$177K ﹤0.01% 2784
2021
Q2 		$462K Buy
+9,962
New +$480K ﹤0.01% 1856

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

HRT Financial's UBX Position: Q3 2025 in Review

HRT Financial sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 34,641 shares — an estimated $13K sold.

HRT Financial first reported a position in UBX in Q2 2021 and held it in 3 quarters. The position peaked at $462K in Q2 2021. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • HRT Financial reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 34,641 Unity Biotechnology shares in Q3 2025, an estimated $13K.
  • HRT Financial first reported a position in Unity Biotechnology in Q2 2021 and held it in 3 quarters.
  • HRT Financial's Unity Biotechnology position peaked at $462K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.